Hi Ramses,
Prana is a new investment that i only added this year (or late last year?)@ 12c so I'm certainly not complaining about their performance to date.
I favor Prima over pbt only because of the dendreon connection and the fact that Prima's CVac will be in phase3 testing first.
I have a lot of confidence in the Prana PBT2 Phase trials and if the timing is right profits from Prima in 2012 might be wisely invested in this coy... interesting year ahead for all biotech investors.
To save from any accusations of cross promoting it should be noted that PRR is certainly out-performing the field this week ;)
idiot, page-14
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
-0.010(3.51%) |
Mkt cap ! $400.0M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.3¢ | 27.0¢ | $1.034M | 3.758M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 98156 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 85523 | 9 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |